E Fund Management Co., Ltd. Beam Therapeutics Inc. Transaction History

E Fund Management Co., Ltd.

  • $1.93 Billion
  • Q3 2024

A detailed history of E Fund Management Co., Ltd. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 12,020 shares of BEAM stock, worth $303,985. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,020
Previous 10,037 19.76%
Holding current value
$303,985
Previous $235,000 25.11%
% of portfolio
0.02%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$22.57 - $33.14 $44,756 - $65,716
1,983 Added 19.76%
12,020 $294,000
Q2 2024

Aug 12, 2024
SELL
$21.22 - $32.66 $32,042 - $49,316
-1,510 Reduced 13.08%
10,037 $235,000
Q1 2024

May 13, 2024
SELL
$23.46 - $45.07 $155,469 - $298,678
-6,627 Reduced 36.46%
11,547 $381,000
Q4 2023

Feb 06, 2024
BUY
$17.69 - $30.76 $12,453 - $21,655
704 Added 4.03%
18,174 $494,000
Q3 2023

Nov 13, 2023
BUY
$23.01 - $32.46 $82,905 - $116,953
3,603 Added 25.98%
17,470 $420,000
Q2 2023

Aug 11, 2023
BUY
$29.32 - $35.99 $54,271 - $66,617
1,851 Added 15.4%
13,867 $443,000
Q1 2023

May 11, 2023
BUY
$30.15 - $48.79 $59,727 - $96,652
1,981 Added 19.74%
12,016 $368,000
Q4 2022

Feb 14, 2023
BUY
$36.73 - $51.6 $64,350 - $90,403
1,752 Added 21.15%
10,035 $392,000
Q3 2022

Nov 14, 2022
SELL
$39.79 - $70.31 $197,119 - $348,315
-4,954 Reduced 37.43%
8,283 $395,000
Q2 2022

Aug 15, 2022
BUY
$29.86 - $62.36 $263,753 - $550,825
8,833 Added 200.57%
13,237 $512,000
Q1 2022

May 12, 2022
BUY
$53.73 - $82.16 $160,975 - $246,151
2,996 Added 212.78%
4,404 $252,000
Q1 2021

May 12, 2021
BUY
$71.28 - $120.75 $100,362 - $170,016
1,408 New
1,408 $112,000

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email